Biden impeachment saga creates a wild new political twist in an unprecedented election
By opening an impeachment investigation into President Joe Biden, House Speaker Kevin McCarthy unleashed an unpredictable and treacherous new political force into what is already the most abnormal election of modern times.
2023-09-14 12:54
Internet calls host Sunny Hostin 'misogynistic' as 'The View' panel discusses woman’s marital conflict
'The View' host Sunny Hostin faced backlash for linking a woman's past relationship with her husband's brother to his inappropriate advances
2023-09-14 12:20
Groundbreaking migraine treatment offers ‘new hope’ for patients
A treatment for acute migraines has been approved for NHS use for the first time, with experts saying the move could be a “step-change” for thousands of people who suffer from the condition. The National Institute for Health and Care Excellence (Nice) said its final draft guidance on Rimegepant “addresses the high unmet need for treatment options for acute migraine”. Rimegepant, also known as Vydura and made by Pfizer, will be available to adults who have tried at least two triptans – medication usually given to tackle headaches or migraines – but found they did not work well enough. It can also be administered to those who are not able to take triptans or have an intolerance, or patients who have tried nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol. Helen Knight, director of medicines evaluation at Nice, said: “Migraine is a condition described in comments to Nice from carers and people with migraine as an invisible disability that affects all aspects of life including work, education, finances, mental health, social activities and family. “Today’s final draft guidance addresses the high unmet need for treatment options for acute migraine, once again demonstrating our ability to ensure clinically and cost-effective medicines are available to those who need them as quickly as possible.” Rimegepant is taken as a wafer, which dissolves under the tongue and works by stopping the release of a protein around the brain called calcitonin gene-related peptide. In July, the medicine was recommended as an option for preventing episodic migraines in adults who have at least four and fewer than 15 attacks per month if “at least” three other treatments have not worked. This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment Helen Knight, Nice Under the latest guidance, it will also be used to relieve symptoms of a migraine, which can include pain, nausea and sensitivity to light, but also painless symptoms such as temporary visual disturbances known as “aura”, which Nice said “is not well managed with existing treatments”. The recommendation is expected to benefit about 13,000 people. Ms Knight added: “This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment.” Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health Robert Music, The Migraine Trust Robert Music, chief executive of The Migraine Trust, said the Nice guidance “provides people with migraine valuable options to help reduce the pain and length of a migraine attack”. “It brings new hope,” he added. “It will especially benefit those who have not found a treatment that works, those who get debilitating side effects – including medicine overuse headache – from them, and those with cardiovascular disease who cannot take existing treatments. “Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health.” Read More NHS winter resilience fund announced by Government NHS reliance on paper notes ‘stopping trusts from realising full potential’ Recession fears as UK economy shrinks by more than expected in shock decline Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live
2023-09-14 11:52
'AGT' Season 18: Fans want NBC to 'just do the results and end the show' instead of airing filler episodes
The viewers of 'AGT' took to social media to criticize the judges, derided the performances, and overall detested the September 13 episode
2023-09-14 11:48
'AGT' Season 18: Viewers disappointed as Anna DeGuzman becomes first woman magician to move to finals
'AGT' fans call Anna DeGuzman 'not a real magician' as Jersey girl moves to finals
2023-09-14 11:27
‘Morning Joe’ host Mika Brzezinski leaves viewers in splits as she interrupts Joe Scarborough’s rant in hilarious on-air moment
Mika Brzezinski interrupted Joe Scarborough as he immitated Rep James Comer after playing clips of an interview given by him
2023-09-14 11:20
Canada’s Wildfires Have Spewed More CO2 Than Mexico Did in a Year
Fires burning across most Canadian provinces and territories since May have released 410 million metric tons of carbon
2023-09-14 10:54
Here's when 'AGT' Season 18 Episode 20 drops: Contestants deliver stunning performances in Qualifier 5
'AGT' Season 18 Qualifier 5 will feature more amazing performances
2023-09-14 10:29
AMC Raises $325 Million Selling Stock Ahead of Taylor Swift Film
AMC Entertainment Holdings Inc. raised about $325.5 million through the sale of 40 million shares, a move that
2023-09-14 10:26
USA Today Is Now Hiring a Beyoncé Reporter After Posting a Taylor Swift Job
First it was Taylor Swift. Now it’s Beyoncé. Fresh off a job ad for a reporter to cover
2023-09-14 09:51
When will 'RHOC' Season 18 air? Bravo's OG cast members continue to explore friendships and relationships
In 'RHOC' Season 18, we may see whether Shannon Beador managed to mend her relationship with other cast members or not
2023-09-14 09:23
‘Today’ host Savannah Guthrie jokes about Craig Melvin’s ‘sexiness’ on-air after host abruptly leaves show
Craig Melvin had to leave 'Today' mid-show on Wednesday, September 13 due to an assignment
2023-09-14 09:22